Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1

Cell

Volumn 97, Issue 5, 1999, Pages 575-586

  Harkin, D Paul ^a,c   Bean, James M ^a   Miklos, David ^a   Song, Young Han ^a   Truong, Vivi B ^c   Englert, Christoph ^a,d   Christians, Fred C ^b   Ellisen, Leif W ^a   Maheswaran, Shyamala ^a,e   Oliner, Jonathan D ^b   Haber, Daniel A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Thermo Fisher Scientific   (United States)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; DOUBLE STRANDED DNA; MESSENGER RNA; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER SUSCEPTIBILITY; DNA DAMAGE; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 0033612303     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80769-2     Document Type: Article

References (44)

1. Andersen, S., Schlegel, B., Nakajima, T., Wolpin, E., and Parvin, J. (1998). BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A. Nat. Genet. 19, 1-3.
2. Chapman, M.S., and Verma, I.M. (1996). Transcriptional activation by BRCA1. Nature 382, 678-679.
3. Chen, Y.R., Wang, X., Templeton, D., Davis, R.J., and Tan, T.H. (1996). The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. J. Biol. Chem. 271, 31929-31936.
4. Cho, R.J., Campbell, M.J., Winzeler, E.A., Steinmetz, L., Conway, A., Wodicka, L., Wolfsberg, T.G., Gabrielian, A.E., Landsman, D., Lockhart, D.J., and Davis, R.W. (1998). A genome-wide transcriptional analysis of the mitotic cell cycle. Mol. Cell 2, 65-73.
5. El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, E., Kinzler, K.W., and Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
6. Fornace, A.J., Jr., Alamo, I., Jr., and Hollander, C. (1988). DNAdamage-inducible transcripts in mammalian cells. Proc. Natl. Acad. Sci. USA 85, 8800-8804.
7. Gossen, M., and Bujard, H. (1992). Tight control of gene expression in mammalian cells by tetracylcline-responsive promoters. Proc. Natl. Acad. Sci USA 89, 5547-5551.
8. Hakem, R., de la Pompa, J.L., Sirard, C., Mo, R., Woo, M., Hakem, A., Wakeham, A., Potter, J., Reitmair, A., Billia, F., et al. (1996). The tumor suppressor gene BRCA1 is required for embryonic cellular proliferation in the mouse. Cell 85, 1009-1023.
9. 5-6 ea-rly embryonic lethality by p53 or p21 null mutation. Nat. Genet. 16, 298-302.
10. Hollander, M.C., Alamo, I., Jackman, J., Wang, M.G., McBride, O.W., and Fornace, A.J., Jr. (1993). Analysis of the mammalian gadd45 gene and its reponse to DNA damage. J. Biol. Chem. 268, 24385-24393.
11. Holt, J., Thompson, M., Szabo, C., Robinson-Benion, C., Arteaga, C., King, M.-C., and Jensen, R. (1996). Growth retardation and tumour inhibition by BRCA1. Nat. Genet. 12, 298-302.
12. Honkoop, A.H., van Diest, P.J., De Jong, J.S., Linn, S.C., Hoekman, G.G.,Wagstaff, J., and Pinedo, H.M.(1998). Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer. Br. J. Cancer 77, 621-626.
13. Hsu, L.-C., and White, R.L. (1998). BRCA1 is associated with the centrosome during mitosis. Proc. Natl. Acad. Sci. USA 95, 12983-12988.
14. Iyer, V.R., Eisen, M.B., Ross, D.T., Schuler, G., Moore, T., Lee, J.C.F., Trent, J.M., Staudt, L.M., Hudson, J., Jr., Boguski, M.S., et al. (1999). The transcriptional program in the response of human fibroblasts to serum. Science 283, 83-87.
15. Jarvis, E.M., Kirk, J.A., and Clark, C.L. (1998). Loss of nuclear BRCA1 expression in breast cancers is associated with a highly proliferative tumor phenotype. Cancer Genet. Cytogenet. 101, 109-115.
16. Kastan, M., Zhan, Q., El-Deiry, W., Carrier, F., Jacks, T., Walsh, W., Plunkett, B., Vogelstein, B., and Fornace, A. (1992). A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71, 587-597.
17. Lane, T., Deng, C., Elson, A., Lyu, M., Kozak, C., and Leder, P. (1995). Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev. 9, 2712-2722.
18. Lim, C.P., Jain, N., and Cao, X. (1998). Stress-induced immediate-early gene, EGR1, involves activation of p38/JNK1. Oncogene 4, 2915-2926.
19. Liu, C.Y., Fleshken-Nikitin, A., Li, S., Zeng, Y., and Lee, W.H. (1996). Inactivation of the mouse BRCA1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev. 90, 2112-2143.
20. Lockhart, D.J., Dong, H., Byrne, M.C., Follettie, M.T., Gallo, M.V., Chee, M.S., Mittmann, M., Wang, C., Kobayashi, M., Horton, H., and Brown, E.L. (1996). Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat. Biotechnol. 14, 1675-1680.
21. Ludwig, T., Chapman, D.L., Papaioannou, V.E., and Efstratiadis, A. (1997). Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev. 11, 1226-1241.
22. Marquis, S., Rajan, J., Wynshaw-Boris, A., Xu, J., and Yin, G.-Y. (1995). The developmental pattern of BRCA1 expression implies a role in differentiation of the breast and other tissues. Nat. Genet. 11, 17-28.
23. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P.A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L.M., Ding, W., et al. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266, 66-71.
24. Monteiro, A.N.A., August, A., and Hanafusa, H. (1996). Evidence for a transcriptional activation function of BRCA1 C-terminal region Proc. Natl. Acad. Sci. USA 93, 13595-13599.
25. Ouichi, T., Monteiro, A.N.A., August, A., Aaronson, S.A., and Hanafusa, H. (1998). BRCA1 regulates p53-dependent gene expression. Proc. Natl. Acad. Sci. USA 95, 2302-2306.
26. Rosette, C., and Karin, M. (1996). Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 275, 1194-1197.
27. Ruffner, H., and Verma, I.M. (1997). BRCA1 is a cell cycle-regulated nuclear phosphoprotein. Proc. Natl. Acad. Sci. USA 94, 7138-7143.
28. Scully, R.S., Andersen, S.F., Chao, D.M., Wei. W., Ye, L., Young, R.A., Livingston, D.M., and Parvin, J.D. (1997a). BRCA1 is a component of the RNA polymerase II holoenzyme. Proc. Natl. Acad. Sci. USA 94, 5605-5610.
29. Scully, R.S., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., and Livingston, D. (1997b). Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88, 265-275.
30. Scully, R.S., Chen, J., Ochs, R.L., Keegan, K., Hoekstra, M., Feunteun, J., and Livingston, D.M. (1997c). Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90, 425-435.
31. Shao, N., Chai, Y., Shyam, E., Reddy, P., and Rao, V. (1996). Induction of apoptosis by the tumor suppressor protein BRCA1 Oncogene 13, 1-7.
32. WAF1/CIP1. Nature 389, 187-190.
33. Takekawa, M., and Saito, H. (1998). A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. Cell 95, 521-530.
34. Thomas, J.E., Smith, M., Tonkinson, J.L., Rubinfeld, B., and Polakis, P. (1997). Induction of phosphorylation on BRCA1 during the cell cycle and after DNA damage. Cell Growth Differ. 8, 801-809.
35. Tomlinson, G.E., Chen, T.T., Stastny, V.A., Virmani, A.K., Spillman, M.A., Tonk, V., Blum, J.L., Schneider, N.R., Wistuba, I.I., Shay, J.W., Minna, J.D., and Gazdar, A.F. (1998). Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. Cancer Res. 58, 3237-3242.
36. Velculescu, V.E., Zhang, L., Vogelstein, B., and Kinzler, K.W. (1995). Serial analysis of gene expression. Science 270, 484-487.
37. Wang, Q., Zhang, H., Kajino, K., and Greene, M.I. (1998). BRCA1 binds c-myc and inhibits its transcriptional and transforming activity in cells. Oncogene 17, 1939-1948.
38. Wilson, C., Payton, M., Elliott, G., Buaas, F., Cajulis, E., Grosshans, C., Ramos, L., Reese, D., Slamon, D., and Calzone, F. (1997). Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-D11b. Oncogene 14, 1-16.
39. Wodicka, L., Dong, H., Mittmann, M., Ho, M.H., and Lockhart, D.J. (1997). Genome-wide expression monitoring in Saccharomyces cerevisiae. Nat. Biotechnol. 15, 1359-1367.
40. Wu, L., Wang, Z., Tsan, J., Spillman, M., Phung, A., Xu, X., Yang, M., Bowcock, L.H.A., and Baer, R. (1996). Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat. Genet. 14, 430-40.
41. Xu, X., Weaver, Z., Linke, S.P., Li, C., Gotay, J., Wang, X.-W., Harris, C.C., Ried, T., and Deng, C.-X. (1999). Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol. Cell 3, 389-395.
42. Yan, M., Dai, T., Deak, J.C., Kyriakis, J.M., Zon, L.I., Woodgett, J.R., and Templeton, D.J. (1994). Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1. Nature 372, 798-800.
43. Yu, X., Wu, L.C., Bowcock, A.M., Aronheim, A., and Baer, R. (1998). The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression. J. Biol. Chem. 273, 25388-25392.
44. Zhang, H., Somasundaram, K., Peng, Y., Tian, H., Zhang, H., Bi, D., Weber, B.L., and El-Deiry, W.S. (1998). BRCA1 physically associates ewith p53 and stimulates its transcriptional activity. Oncogene 16, 1713-1721.